Arcturus Therapeutics to Present at Jefferies London Healthcare Conference
Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...
14-year-old boy sought in connection with deadly Arcturus Lane shooting turns himself in
The Mobile Police Department is looking for a third teen in connection with a Halloween night shooting that claimed the life ...
Arcturus: LUNAR-CF For CF Presses On With 1st Half Of 2025 Interim Data
Arcturus Therapeutics expects interim results for LUNAR-CF and LUNAR-OTC in 2025. Learn why ARCT stock presents an ...
New details in the deadly Arcturus Lane shooting
Forty-four-year-old Anthony Green is accused of shooting another man multiple times during an argument on Nov. 4, 2024. Nyyon ...
WKRG6d
UPDATE: 14-year-old wanted in connection with Mobile homicide turns himself in
This story has been updated to remove the name of a 14-year-old suspect due to him no longer being a public safety threat.
Upstream4d
Intrigue builds over ExxonMobil's completed African wildcat
Intrigue surrounding the outcome of an ExxonMobil wildcat in Angola’s frontier Namibe basin continues to build, more than ...
Arcturus Therapeutics Announces Third Quarter 2024 Financial Update and Pipeline Progress
Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...
ETF Daily News7d
Arcturus Therapeutics (NASDAQ:ARCT) Receives Buy Rating from HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of Arcturus Therapeutics (NASDAQ:ARCT – Free Report) in a research report ...
Arcturus Therapeutics: Strong Buy Rating Backed by Promising Kostaive Sales and Promising Pipeline Developments
Arcturus Therapeutics (ARCT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Ed ...
WKRG Mobile on MSN9d
Family of Mobile teenager killed on Halloween speaks out
The family of a teenager who was shot and killed on Halloween is speaking out and seeking answers. Karsyn Pryor, 15, was ...
Analysts Set Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) PT at $71.40
Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Get Free Report) have earned an average recommendation of “Buy” ...
Business Insider8d
Arcturus Therapeutics: Strategic Growth and Robust Pipeline Justify Buy Rating
Arcturus Therapeutics (ARCT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on November 7. Analyst Lili (Aurélie) Nsongo from Leerink Partners maintained a ...